Today: 9 June 2026
Why ACM Research (ACMR) stock is jumping today — and what investors are watching next
2 January 2026
1 min read

Why ACM Research (ACMR) stock is jumping today — and what investors are watching next

NEW YORK, Jan 2, 2026, 12:33 PM ET — Regular session

ACM Research shares jumped 10.6% to $43.64 in midday trading on Friday, after swinging between $40.26 and $44.20 earlier in the session.

The sharp move put the Nasdaq-listed semiconductor equipment maker among the day’s stronger gainers in the chip sector, as investors rotated back into technology on the first trading day of 2026.

The rally matters now because ACM Research is heading into a key January stretch where investors will be looking for fresh signals on demand for chipmaking tools. The Fremont, California-based company has said it will release its preliminary 2025 revenue range and initial 2026 revenue outlook on Jan. 22, and will also take part in the Needham Growth Conference on Jan. 15.

Semiconductor equipment stocks were broadly higher, with Lam Research up about 5.1%, Applied Materials up about 3.4% and KLA up about 3.2%. ASML’s U.S.-listed shares were up about 8.4%.

The advance came alongside a wider rebound in U.S. equities, after technology shares led Wall Street higher in early 2026 trading, Reuters reported.

In Europe, attention centered on ASML after Aletheia Capital upgraded the chip-equipment maker and doubled its price target to $1,500, citing stronger demand for extreme ultraviolet lithography, or EUV, a key step in producing the most advanced chips.

ACM Research makes semiconductor process tools used in steps such as wafer cleaning and electroplating, as well as equipment for advanced packaging, according to Reuters company information.

For ACM Research, the next catalyst is less about day-to-day market swings and more about what its January update says about customer spending plans for 2026. Traders typically focus on the revenue outlook first, then watch for clues on margins and the pace of new tool adoption.

Analysts will also be measuring the company against near-term expectations. A recent Zacks commentary published on Nasdaq.com said analysts were projecting earnings of $0.39 per share on revenue of $244.45 million for the upcoming report period.

Beyond company-specific news, investors are bracing for macro data that can move rate expectations — a key driver for growth stocks. The U.S. jobs report due Jan. 9 and consumer inflation data due Jan. 13 are among the early tests, Reuters reported; “The market is looking for direction,” Matthew Maley, chief market strategist at Miller Tabak, said. Reuters

ACM Research’s surge also underlined how quickly semiconductor equipment shares can react when risk appetite returns. Those moves can fade just as fast if incoming data or guidance points to slower factory spending.

Stock Market Today

  • Semiconductor Stock Poised to Surpass Micron Technology by 2028
    June 9, 2026, 10:18 AM EDT. Micron Technology has surged nearly 800% recently, driven by high demand and pricing power in memory chips, pushing its market cap past $1 trillion. However, analysts predict supply constraints easing by 2028 could cause earnings to peak and decline, potentially halving share value to around $517.50. Meanwhile, a major semiconductor competitor valued around $650 billion is expanding production, potentially surpassing Micron's value by 2028. The industry faces cyclical dynamics as new manufacturing capacity comes online globally, impacting pricing and earnings. Investors are watching these shifts closely for long-term positioning amid evolving chip supply and demand.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Interstellar comet 3I/ATLAS spills its secrets as scientists clock its water loss and radio silence
Previous Story

Interstellar comet 3I/ATLAS spills its secrets as scientists clock its water loss and radio silence

Hubble spots odd triple jets on interstellar comet 3I/ATLAS as radio search finds no alien signal
Next Story

Hubble spots odd triple jets on interstellar comet 3I/ATLAS as radio search finds no alien signal

Go toTop